BIOMAT Database Logo BIOMAT Database Logo

The potential of acyclic nucleoside phosphonates as broad-spectrum antiviral agents. 1995

L Naesens, and J Balzarini, and E De Clercq
Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium.

UI MeSH Term Description Entries
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D003596 Cytosine A pyrimidine base that is a fundamental unit of nucleic acids.
D006566 Herpesviridae Infections Virus diseases caused by the HERPESVIRIDAE. Herpesvirus Infections,B Virus Infection,Infections, Herpesviridae,Infections, Herpesvirus,B Virus Infections,Herpesviridae Infection,Herpesvirus Infection,Infection, B Virus,Infection, Herpesviridae,Infection, Herpesvirus,Infections, B Virus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077404 Cidofovir An acyclic nucleoside phosphonate that acts as a competitive inhibitor of viral DNA polymerases. It is used in the treatment of RETINITIS caused by CYTOMEGALOVIRUS INFECTIONS and may also be useful for treating HERPESVIRUS INFECTIONS. 1-((3-Hydroxy-2-phosphonylmethoxy)propyl)cytosine,1-(3-Hydroxy-2-phosphonylmethoxypropyl)cytosine,Cidofovir Anhydrous,Cidofovir Sodium,Cidofovir, (+-)-isomer,Cidofovir, (R)-isomer,Cidofovir, Sodium Salt,GS 504,GS-504,HPMPC,Vistide,GS504
D000225 Adenine A purine base and a fundamental unit of ADENINE NUCLEOTIDES. Vitamin B 4,4, Vitamin B,B 4, Vitamin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012192 Retroviridae Infections Virus diseases caused by the RETROVIRIDAE. Retrovirus Infections,Infections, Retroviridae,Infections, Retrovirus,XMRV Infection,Xenotropic MuLV-related Virus Infection,Xenotropic Murine Leukemia Virus-related Virus Infection,Infection, Retroviridae,Infection, Retrovirus,Infection, XMRV,Infections, XMRV,Retroviridae Infection,Retrovirus Infection,XMRV Infections,Xenotropic MuLV related Virus Infection,Xenotropic Murine Leukemia Virus related Virus Infection
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer

Related Publications

L Naesens, and J Balzarini, and E De Clercq
[Acyclic nucleoside phosphonates as potential antineoplastic agents].
January 2008, Casopis lekaru ceskych,
L Naesens, and J Balzarini, and E De Clercq
Antiviral acyclic nucleoside phosphonates structure activity studies.
September 2006, Antiviral research,
L Naesens, and J Balzarini, and E De Clercq
Acyclic nucleoside phosphonates: a key class of antiviral drugs.
November 2005, Nature reviews. Drug discovery,
L Naesens, and J Balzarini, and E De Clercq
Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates.
April 1995, Molecular pharmacology,
L Naesens, and J Balzarini, and E De Clercq
Cytostatic activity of antiviral acyclic nucleoside phosphonates in rodent lymphocytes.
November 2003, Toxicology and applied pharmacology,
L Naesens, and J Balzarini, and E De Clercq
Synthesis of acyclic 6,7-dihaloquinolone nucleoside analogues as potential antibacterial and antiviral agents.
June 2000, Bioorganic & medicinal chemistry,
L Naesens, and J Balzarini, and E De Clercq
Synthesis of acyclic nucleoside phosphonates.
October 2005, Current protocols in nucleic acid chemistry,
L Naesens, and J Balzarini, and E De Clercq
Expanding the Antiviral Spectrum of 3-Fluoro-2-(phosphonomethoxy)propyl Acyclic Nucleoside Phosphonates: Diamyl Aspartate Amidate Prodrugs.
July 2017, Journal of medicinal chemistry,
L Naesens, and J Balzarini, and E De Clercq
Novel antiviral C5-substituted pyrimidine acyclic nucleoside phosphonates selected as human thymidylate kinase substrates.
January 2011, Journal of medicinal chemistry,
L Naesens, and J Balzarini, and E De Clercq
Broad-spectrum antiviral agents.
January 2015, Frontiers in microbiology,
Copied contents to your clipboard!